12-10-2020, 10:00 AM
A single dose arm would have been interesting. Seems highly effective after one dose. Given the supply constraints, a highly effective single dose would be much better at saving lives/ending pandemic even if efficacy is more like 80-85% compared to 90-95%.
Doubt Pfizer would go along with that sort of study now that they are on brink of approval. And very unlikely FDA would approve that dose regimen without a study. Will have to wait for retrospective data on people who only got one dose for whatever reason to tease out more fully.
Doubt Pfizer would go along with that sort of study now that they are on brink of approval. And very unlikely FDA would approve that dose regimen without a study. Will have to wait for retrospective data on people who only got one dose for whatever reason to tease out more fully.